Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMEA recommends changes in the storage conditions for Neupro (rotigotine) 4 Ιούνιος 2008Press release Celgene Europe Limited withdraws its marketing authorisation application for Lenalidomide Celgene Europe (lenalidomide) 4 Ιούνιος 2008Press release Meeting highlights from the Committee for Medicinal Products for Human Use,27-30 May 2008 2 Ιούνιος 2008Press releaseHuman Sanofi-aventis withdraws its marketing authorisation application forAquilda (satavaptan) 28 Μάιος 2008Press release Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisationapplication for DuoCover 27 Μάιος 2008Press release Sanofi Pharma Bristol-Myers Squibb SNC withdraws its marketing authorisation application for DuoPlavin 27 Μάιος 2008Press release DOR BIOPHARMA UK Ltd withdraws marketing authorisation application for orBec (beclomethasone dipropionate) 23 Μάιος 2008Press release Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 13-15 May 2008 16 Μάιος 2008Press releaseVeterinary Meeting highlights from the Paediatric Committee: 6 - 8 May 2008 15 Μάιος 2008Press releaseHumanPaediatrics European Medicines Agency notified of recall of swine fever vaccine (Porcilis Pesti) by Intervet International BV 5 Μάιος 2008Press releaseMedicines 1 … 313 314 315 316 317 Page 317 of 384 318 319 320 321 … 384
EMEA recommends changes in the storage conditions for Neupro (rotigotine) 4 Ιούνιος 2008Press release
Celgene Europe Limited withdraws its marketing authorisation application for Lenalidomide Celgene Europe (lenalidomide) 4 Ιούνιος 2008Press release
Meeting highlights from the Committee for Medicinal Products for Human Use,27-30 May 2008 2 Ιούνιος 2008Press releaseHuman
Sanofi-aventis withdraws its marketing authorisation application forAquilda (satavaptan) 28 Μάιος 2008Press release
Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisationapplication for DuoCover 27 Μάιος 2008Press release
Sanofi Pharma Bristol-Myers Squibb SNC withdraws its marketing authorisation application for DuoPlavin 27 Μάιος 2008Press release
DOR BIOPHARMA UK Ltd withdraws marketing authorisation application for orBec (beclomethasone dipropionate) 23 Μάιος 2008Press release
Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 13-15 May 2008 16 Μάιος 2008Press releaseVeterinary
Meeting highlights from the Paediatric Committee: 6 - 8 May 2008 15 Μάιος 2008Press releaseHumanPaediatrics
European Medicines Agency notified of recall of swine fever vaccine (Porcilis Pesti) by Intervet International BV 5 Μάιος 2008Press releaseMedicines